Pilot Study Using Oral Capsule FMT to Decolonize GI CRE

Status Withdrawn

Clinical Trial Summary

Carbapenem-Resistant Enterobacteriaceae (CRE) are bacteria that have become resistant to carbapenems by producing enzymes that break down carbapenems. The prevalence of CRE continues to rise globally but the treatment options are extremely limited. In case series, isolation of CRE from any site, whether there is clinical infection or not, has been associated with all-cause hospital mortality ranging from 29% to 52%. There are no known methods for reliably decolonizing gastrointestinal (GI) CRE. In rare case reports, fecal microbiota transplant (FMT) has successfully eradicated gastrointestinal colonization of CRE, but there has been no larger study further investigating this. FMT via oral capsules is the least invasive method and has demonstrated efficacy and short-term safety in treating patients with recurrent Clostridium difficile infections. Therefore, the investigators propose this pilot study to determine the effectiveness of oral capsule fecal transplantation in the decolonization of gastrointestinal CRE.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03527056
Study type	Interventional
Source	University of California, Los Angeles
Contact
Status	Withdrawn
Phase	Early Phase 1
Start date	June 2019
Completion date	September 24, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04436874` - Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease	N/A
Recruiting	`NCT03325855` - Fecal Microbiota Transplant National Registry
Completed	`NCT06162702` - Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)	N/A
Active, not recruiting	`NCT05607745` - Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study	N/A
Completed	`NCT05121285` - Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient	N/A
Active, not recruiting	`NCT05917379` - The Safety and Efficacy of FMT in Patients With CID	Phase 1/Phase 2
Recruiting	`NCT02318147` - Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)	Phase 1
Completed	`NCT02318134` - Fecal Microbiota Transplantation for Pancreatitis	Phase 2
Completed	`NCT05035784` - RCE With FMT in the Treatment of Childhood Constipation	N/A
Active, not recruiting	`NCT04173208` - Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study	N/A
Terminated	`NCT04577729` - The IRMI-FMT Trial	N/A
Not yet recruiting	`NCT02435160` - The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis	Phase 2/Phase 3
Recruiting	`NCT04837313` - Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipation	N/A
Recruiting	`NCT04861649` - Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition	N/A
Withdrawn	`NCT04078581` - Profiling Fecal Samples for Selection of Donors of Feces	N/A
Recruiting	`NCT05821010` - Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis	Phase 2
Recruiting	`NCT05273255` - Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy	N/A
Not yet recruiting	`NCT05253222` - Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET	N/A
Recruiting	`NCT04285424` - FMT for Steroid Resistant Gut Acute GVHD	Early Phase 1
Recruiting	`NCT03016780` - Fecal Microbiota Transplantation for Ulcerative Colitis	Phase 1/Phase 2